Schedule 13D ownership disclosure
Tectonic Therapeutic Inc
Common Stock, $0.0001 par value per share · CUSIP: 878972108
Event date: 2025-04-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Terrance McGuireReported CIK 0001117003
Shares: 657,976 · Class: 6.3%
- Polaris Partners IX, L.P.Reported CIK 0001779755
Shares: 573,062 · Class: 3.1%
- Polaris Partners GP IX, L.L.C.Reported CIK 0001877150
Shares: 573,062 · Class: 3.1%
- Polaris Founders Capital Fund I, L.P.
Shares: 20,262 · Class: 0.1%
- Polaris Founders Capital Fund Management Co. I, L.L.C.
Shares: 20,262 · Class: 0.1%
- Polaris Founders Capital Fund II, L.P.
Shares: 64,652 · Class: 0.3%
- Polaris Founders Capital Fund Management Co. II, L.L.C.
Shares: 64,652 · Class: 0.3%
- Jonathan FlintReported CIK 0001295676
Shares: 84,914 · Class: 0.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-051678
- Form type
- SCHEDULE 13D/A
- Filer
- MCGUIRE TERRANCE
- CIK
- CIK 1117003
- Filed
- Apr 07, 2025
- Reporting period
- Apr 03, 2025
- Description
- Schedule 13D beneficial ownership